LIMITED ACTIVITY OF BACTERIAL-DNA TOPOISOMERASE-II INHIBITORS AGAINST LEISHMANIA DONOVANI AND TRYPANOSOMA-CRUZI AMASTIGOTES INVITRO

被引:28
|
作者
CROFT, SL [1 ]
HOGG, J [1 ]
机构
[1] WELLCOME RES LABS,BECKENHAM BR3 3BS,KENT,ENGLAND
关键词
D O I
10.1016/0035-9203(88)90017-X
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:856 / 856
页数:1
相关论文
共 41 条
  • [31] In Vitro and in Vivo Activity of mTOR Kinase and PI3K Inhibitors Against Leishmania donovani and Trypanosoma brucei
    Phan, Trong-Nhat
    Baek, Kyung-Hwa
    Lee, Nakyung
    Byun, Soo Young
    Shum, David
    No, Joo Hwan
    MOLECULES, 2020, 25 (08):
  • [32] Synthesis, evaluation of the biological activity against Trypanosoma cruzi and Leishmania donovani. Preliminary in silico ADMET studies of 5-nitroimidazole derivatives
    Rodriguez, Miguel A.
    Mijoba, Ali
    Parra-Gimenez, Nereida J.
    Blanco, Zuleyma
    Chavez, Katiuska
    Suarez, Alirica I.
    Fernandez-Moreira, Esteban
    Ramirez, Hegira
    Charris, Jaime E.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS, 2025, 13
  • [33] INTERLEUKIN-3 INDUCES ANTIMICROBIAL ACTIVITY AGAINST LEISHMANIA-AMAZONENSIS AND TRYPANOSOMA-CRUZI AND TUMORICIDAL ACTIVITY IN HUMAN PERIPHERAL BLOOD-DERIVED MACROPHAGES
    HO, JL
    REED, SG
    SOBEL, J
    ARRUDA, S
    HE, SH
    WICK, EA
    GRABSTEIN, KH
    INFECTION AND IMMUNITY, 1992, 60 (05) : 1984 - 1993
  • [34] Differential induction of Leishmania donovani bi-subunit topoisomerase I-DNA cleavage complex by selected flavones and camptothecin:: activity of flavones against camptothecin-resistant topoisomerase I
    Das, BB
    Sen, N
    Roy, A
    Dasgupta, SB
    Ganguly, A
    Mohanta, BC
    Dinda, B
    Majumder, HK
    NUCLEIC ACIDS RESEARCH, 2006, 34 (04) : 1121 - 1132
  • [35] ACTIVITY OF INTOPLICINE (RP60475), A NEW DNA TOPOISOMERASE-I AND TOPOISOMERASE-II INHIBITOR, AGAINST HUMAN TUMOR COLONY-FORMING-UNITS IN-VITRO
    ECKARDT, JR
    BURRIS, HA
    KUHN, JG
    BISSERY, MC
    KLINKALAKL, M
    CLARK, GM
    VONHOFF, DD
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (01) : 30 - 33
  • [36] Optimization of physicochemical properties and safety profile of novel bacterial topoisomerase type II inhibitors (NBTIs) with activity against Pseudomonas aeruginosa
    Reck, Folkert
    Ehmann, David E.
    Dougherty, Thomas J.
    Newmana, Joseph V.
    Hopkins, Sussie
    Stone, Gregory
    Agrawal, Nikunj
    Ciaccio, Paul
    McNulty, John
    Barthlow, Herbert
    O'Donnell, Jennifer
    Goteti, Kosalaram
    Breen, John
    Comita-Prevoir, Janelle
    Cornebise, Mark
    Cronin, Mark
    Eyermann, Charles J.
    Geng, Bolin
    Carr, Greg R.
    Pandarinathan, Lakshmipathi
    Tang, Xuejun
    Cottone, Andrew
    Zhao, Liang
    Bezdenejnih-Snyder, Natascha
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (19) : 5392 - 5409
  • [37] SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIP OF METHYL-SUBSTITUTED INDOLE[2,3-B]QUINOLINES - NOVEL CYTOTOXIC, DNA TOPOISOMERASE-II INHIBITORS
    PECZYNSKACZOCH, W
    POGNAN, F
    KACZMAREK, L
    BORATYNSKI, J
    JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (21) : 3503 - 3510
  • [38] ALTERATION OF DNA TOPOISOMERASE-II ACTIVITY DURING INFECTION OF H9 CELLS BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INVITRO - A TARGET FOR POTENTIAL THERAPEUTIC AGENTS
    MATTHES, E
    LANGEN, P
    BRACHWITZ, H
    SCHRODER, HC
    MAIDHOF, A
    WEILER, BE
    RENNEISEN, K
    MULLER, WEG
    ANTIVIRAL RESEARCH, 1990, 13 (06) : 273 - 286
  • [39] Development and use of a high-throughput bacterial DNA gyrase assay to identify mammalian topoisomerase II inhibitors with whole-cell anticancer activity
    Roychoudhury, S
    Makin, KM
    Twinem, TL
    Stanton, DT
    Nelson, SL
    Catrenich, CE
    JOURNAL OF BIOMOLECULAR SCREENING, 2003, 8 (02) : 157 - 163
  • [40] DRUG FEATURES THAT CONTRIBUTE TO THE ACTIVITY OF QUINOLONES AGAINST MAMMALIAN TOPOISOMERASE-II AND CULTURED-CELLS - CORRELATION BETWEEN ENHANCEMENT OF ENZYME-MEDIATED DNA CLEAVAGE IN-VITRO AND CYTOTOXIC POTENTIAL
    ELSEA, SH
    MCGUIRK, PR
    GOOTZ, TD
    MOYNIHAN, M
    OSHEROFF, N
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (10) : 2179 - 2186